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Abstract  Mucin-producing  tumors  of  the  ovary  can  be  either  primary  epithelial  mucin-
producing  tumors  or  ovarian  metastases  from  a  remote  adenocarcinoma  usually  originating
from the  gastrointestinal  tract.  The  purpose  of  this  pictorial  review  is  to  describe  the  main
types of  primary  or  secondary  mucin-producing  tumors  of  the  ovary  and  to  provide  MR  imaging
diagnostic  criteria  in  order  to  guide  further  therapy.Ovarian  metastases;
© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
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Mucin-producing  tumors  of  the  ovary  can  be  either  primary
epithelial  mucin-producing  tumors  or  ovarian  metastases
from  a  remote  adenocarcinoma  usually  originating  from  the
gastrointestinal  tract.
The  World  Health  Organization’s  classiﬁcation  of  ovarian
tumors  differentiates  the  following  four  main  categories:
epithelial  tumors,  germ  cell  tumors,  sex-cord  and  stromal
tumors,  and  ovarian  metastases  (Boxed  text  1).
Epithelial  tumors  represent  60%  of  all  ovarian  tumors  and
85%  of  malignant  tumors  [1].  They  originate  from  the  sur-
face  epithelium  of  the  ovary.  Their  classiﬁcation  depends
both  on  the  cell  type  of  the  epithelium,  of  which  there  are
ﬁve  (serous,  mucinous,  endometrioid,  clear  cell  and  Brenner
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orderline  and  malignant).  Epithelial  mucinous  tumors  make
p  between  15  and  20%  of  ovarian  lesions  depending  on  the
eries.  Ovarian  metastases  represent  approximately  5%  of  all
varian  tumors.  The  ovary  is  a  common  site  for  metastases.
he  primary  cancers  that  give  ovarian  mucinous  metastases,
riginate  from  the  gastrointestinal  tract  [2].
Differential  diagnosis  between  these  primary  and  sec-
ndary  mucinous  lesions  is  critical  for  optimizing  treatment
lanning:  indeed,  if  the  radiologist  concludes  that  the  ovar-
an  lesion  is  secondary,  complete  staging  will  be  performed
o  ﬁnd  the  primary  cancer,  particularly  by  ﬁbroscopy  and
oloscopy.  Treatment  will  then  start  with  initial  chemother-
py.  On  the  other  hand,  if  the  radiologist  concludes  that  the
umor  is  a  primary  ovarian  tumor,  an  additional  CT  examina-
ion  will  be  performed  to  look  for  peritoneal  carcinomatosis,
nd  then  the  treatment  will  begin  with  initial  pelvic  surgery.
owever,  it  is  sometimes  difﬁcult  to  differentiate  between
r Masson SAS. All rights reserved.
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Boxed  text  1:  WHO  classiﬁcation  of  ovarian  tumors.
Classiﬁcation  of  ovarian  tumors
Epithelial  tumors
Serous  tumors
Mucinous  tumors
Endometrioid  tumors
Clear  cell  tumors
Brenner  tumors
Germ  cell  tumors
Teratoma
Mature  (dermoid  cyst)
Immature
Dysgerminoma
Embryonal  carcinoma
Yolk  sac  tumor  (endodermal  sinus  tumor)
Choriocarcinoma
Sex-cord  and  stromal  tumors
Gonadal  stromal  tumors
Fibroma
Thecoma  (Fibrothecoma)
Sclerosing  stromal  tumor
Sex-cord  tumors
Granulosa  tumors
Sertoli-Leydig  cell  tumors
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rimary  and  secondary  mucinous  lesions  with  both  imaging
nd  histopathological  analysis.
The  purpose  of  this  pictorial  review  is  to  describe  the
ain  types  of  primary  or  secondary  mucin-producing  tumors
f  the  ovary  and  to  provide  MR  imaging  diagnostic  criteria,
n  order  to  guide  further  therapy.
pithelial mucinous tumors of the ovary
pithelial  mucinous  tumors  of  the  ovary  represent  15  to  20%
f  all  ovarian  tumors.  These  tumors  are  considered  muci-
ous  because  their  epithelium  secretes  mucin.  Depending  on
he  histological  degree  of  malignancy,  epithelial  mucinous
umors  may  be  benign  cystadenomas  (85%),  borderline  cys-
adenomas  (10%),  or  mucinous  cystadenocarcinomas  (5%).
he  benign  forms  occur  preferentially  between  30  and
0  years  of  age  and  the  borderline  and  malignant  forms
etween  40  and  70.  Epithelial  mucinous  tumors  have  the
ollowing  common  characteristics:  they  appear  multilocu-
ar  both  macroscopically  and  in  images,  and  they  are  large,
ften  exceeding  10  cm  [3].  Unlike  serous  lesions,  they  are
enerally  unilateral.  Occurrence  associated  with  a  Brenner
umor  is  classic  [4].
enign mucinous cystadenomaistological appearance
ucinous  cystadenoma  typically  presents  as  a unilat-
ral,  multilocular,  voluminous,  cystic,  ovarian  lesion.
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acroscopically,  the  content  is  mucoid  (Fig.  1).  A  benign
ucinous  cystadenoma  has  no  solid  portion.  Its  wall  is
mooth  but  may  sometimes  have  a  few  papillary  projections
1].
Microscopically,  a  benign  mucinous  cystadenoma  is  lined
y  a  tall  columnar  epithelium,  with  basal  nuclei  secreting
ucin.  This  layer  is  seen  in  large  cystic  structures,  the  lumen
f  which  is  ﬁlled  with  a  considerable  quantity  of  mucus.  In  5%
f  cases,  benign  mucinous  cystadenomas  can  be  combined
ith  other  ovarian  tumors:  Brenner  tumors  and  dermoid
ysts.
RI appearance
n  MRI  benign  mucinous  cystadenoma  typically  presents
s  a  large,  multilocular,  cystic,  ovarian  lesion.  Some  loculi
re  spontaneously  hyperintense  on  T1-weighted  MR  images
related  to  the  variable  concentration  of  mucin  in  the
oculi).  These  loculi  are  more  or  less  grouped  together  some-
imes  giving  a  ‘‘honeycomb’’  or  ‘‘stained  glass’’  pattern
1,5]  (Fig.  1).  The  criterion  indicating  a benign  lesion  is  the
bsence  of  areas  of  tissue  (the  absence  of  irregular  septa
r  solid  portions)  [6]. Papillary  projections  are  uncommon
nd  when  present,  are  very  small  and  difﬁcult  to  see  with
maging  [7].
orderline mucinous cystadenoma
istological appearance
his  is  a  multilocular  cystic  ovarian  lesion  characterized  by
he  presence  of  irregular  septa  and  papillary  projections.
orderline  mucinous  cystadenoma  papillae  are  often  smaller
han  the  serous  type,  sometimes  only  visible  on  microscopic
xamination  [1,8].  The  microscopic  appearance  of  a  bor-
erline  tumor  is  that  of  cystic  structures  bordered  by  a
roliferating  epithelium  with  discreet  to  moderate  cytonu-
lear  atypia  with  no  stromal  invasion  (Fig.  2).
RI appearance
he  MRI  appearance  is  very  similar  to  benign  mucinous  cys-
adenoma:  a  multilocular  cystic  mass  with  large  loculi  of
ariable  intensity  on  T1-weighted  MR  images.  The  presence
f  irregular  septal  or  groups  of  small  papillary  projections
oint  toward  diagnosis  of  a  borderline  mucinous  lesion  [9].
he  small  papillary  projections  are  most  often  hypointense
n  T2-weighted  MR  images.  The  presence  of  a large  number
f  loculi  can  also  point  toward  the  borderline  type  [10].
ucinous cystadenocarcinoma
istological appearance
ucinous  cystadenocarcinoma  is  an  invasive  malignant
umor  presenting  as  a  large  (>  10  cm),  multilocular,  cystic
esion,  which  is  usually  unilateral.  Mucinous  cystadenocar-
inoma  is  rarely  bilateral  (7%).  The  criteria  indicating  a
ystadenocarcinoma  are  the  presence  of  one  or  more  solid
arts  (tumor  nodule)  and  irregular  septa.  Microscopically,
he  cytological  criteria  of  malignancy  are  associated  with
esmoplasia,  indicating  the  invasive  character  of  the  carci-
oma.  It  is  often  difﬁcult  to  detect  the  presence  of  areas  of
nvasion  and  multiple  samples  have  to  be  obtained,  due  to
MRI  of  ovarian  mucin-producing  tumors  1127
Figure 1. Benign mucinous cystadenoma; a: T2-weighted MR image in the sagittal plane; b: T2-weighted MR image in the axial plane;
c: T1-weighted MR image in the axial plane; d: T1-weighted fat-suppressed MR image in the axial plane after intravenous administration
of a gadolinium chelate shows presence of loculi of variable intensity (arrows); e: photograph shows gross appearance after opening; f:
multilocular cystic lesion with thick mucoid content and no solid part. Histological appearance (×20 magniﬁcation), cyst wall lined by a
single layer of columnar epithelium with a secretory pole. Absence of cytonuclear atypia.
Figure 2. Borderline mucinous cystadenoma; a: T2-weighted MR image in the sagittal plane; b: T1-weighted fat-suppressed MR image
in the axial plane; c: T1-weighted fat-suppressed MR image in the axial plane after intravenous administration of a gadolinium chelate
shows a group of loculi (black arrow) and irregular septa (white arrow); d, e: photographs show gross appearance before (d) and after (e)
opening. The tumor is a multilocular cystic lesion with mucoid content and many papillary projections (arrow); f: histological appearance
[×10 magniﬁcation]), more or less cystic glandular structures edged by a multistratiﬁed epithelium and containing moderate cytonuclear
atypia are present.
1128  P.-E.  Laurent  et  al.
Figure 3. Mucinous cystadenocarcinoma; a: T2-weighted MR image in the axial plane shows solid portion of intermediate signal intensity
(arrows); b: T1-weighted MR image in the axial plane; c: diffusion-weighted MR image in the axial plane shows solid portions of hypersignal
intensity (arrows); d: T1-weighted fat-suppressed MR image in the axial plane after intravenous administration of a gadolinium chelate
shows enhancing portions (arrows); e: photographs show gross appearance before opening. The tumor is cystic with a solid portion (arrow)
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af ﬁrm consistency and necrotic content; f: histological appearan
nvasion and presence of marked cytonuclear atypia.
he  frequent  association  of  benign,  borderline  and  malignant
arts  within  the  lesion  (Fig.  3).
RI appearance
n  MRI  mucinous  cystadenocarcinoma  typically  presents  as
 multilocular  cystic  lesion  containing  a  solid  part  of  inter-
ediate  intensity  on  T2-weighted  MR  images,  hyperintense
n  diffusion-weighted  images,  and,  on  perfusion  sequences,
ith  a  type-3  enhancement  curve  (earlier  enhancement  rel-
tive  to  the  myometrial  curve)  [11]  (Fig.  3).  The  spread
lsewhere  (lymph  node  or  peritoneum)  is  also  an  indication
f  a  malignant  lesion.
ifferential diagnosis
he  principal  differential  diagnoses  for  epithelial  mucinous
umors  are  ovarian  metastases  and  serous  epithelial  tumors.
varian metastases
he  main  primary  sites  of  ovarian  metastases  are  the  colon,
tomach,  breast,  and  appendix.  The  macroscopic  and  imag-
ng  appearance  of  these  lesions  varies  with  the  primary
ancer.  Two  types  of  secondary  ovarian  lesion  should  be
learly  separated:  ovarian  metastases  where  the  major  com-
onent  is  solid,  and  metastases  which  are  predominantly
ystic.
b
m
t0 magniﬁcation. There is dense tumor proliferation with stromal
redominantly solid metastases (Krukenberg
umors)
redominantly  solid  secondary  lesions  or  Krukenberg  tumors
KT)  will  not  be  covered  in  detail  in  this  review.  Indeed,
hey  rarely  pose  a  problem  of  differential  diagnosis  with
pithelial  mucinous  tumors.
KT  is  often  erroneously  used  for  all  ovarian  lesions  sec-
ndary  to  a  primary  gastric  tumor  or  even  for  all  ovarian
etastases,  but  this  term  has  a  strict  anatomopathologi-
al  deﬁnition:  signet  ring  cells  making  up  at  least  10%  of
he  tumor.  The  typical  macroscopic  appearance  is  a  ﬁbrous
tromal  component,  explaining  the  predominantly  solid
ppearance  on  MRI.  The  primary  sites  of  KT,  in  decreasing
rder,  are  the  stomach,  and  more  particularly  gastric  linitis
lastica,  the  colon,  and  the  breast.
redominantly cystic metastases
non-Krukenberg  type)
hese  are  ovarian  mucin-producing  metastases.  Only  certain
rimary  cancer  sites  produce  this  type  of  ovarian  metastatic
esion.  In  decreasing  order,  they  are  the  colon,  the  pancreas,
he  stomach  and  the  appendix  [2,12].  Mucus-secreting  ovar-
an  metastases  of  the  gall  bladder,  cervix  and  lungs  are  rare
nd  are  not  covered  in  this  review.The  radiologist’s  main  objective  is  to  differentiate
etween  primary  mucinous  ovarian  tumors  and  cystic
etastasis  from  a  gastrointestinal  tract  cancer,  because
herapeutic  management  is  different.  The  two  main  criteria
MRI  of  ovarian  mucin-producing  tumors  1129
Figure 4. Left ovarian metastasis from colorectal adenocarcinoma; a: T2-weighted MR image in the axial plane. Multilocular formation
with necrotic components which are hyperintense; b: T1-weighted MR image in the axial plane. Multilocular formation with loculi of variable
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in the sagittal plane after intravenous administration of a gadoliniu
are  the  size  of  the  lesions  and  whether  they  are  unilateral
or  bilateral:  primary  (epithelial)  malignant  mucinous  tumors
are  generally  larger  and  very  commonly  unilateral  (>  80%).
It  has  been  suggested  that  bilateral  lesions  or  unilateral
lesions  <  10  cm  indicate  a  metastatic  origin  whereas  unilat-
eral  lesions  measuring  >  10  cm  indicate  a  primary  epithelial
origin  [3,13].
These  Seidman  criteria  have  since  been  tested  on  a  series
of  74  cases  [14].  The  authors  concluded  that  the  ‘‘lesion
measuring  less  than  10  cm  or  bilateral  involvement’’  crite-
rion  was  of  good  diagnostic  value  for  secondary  locations.  On
the  other  hand,  the  ‘‘unilateral  lesions  measuring  more  than
10  cm’’  criterion  seemed  to  be  less  reproducible.  Indeed  in
this  series,  of  21  unilateral  lesions  >  10  cm,  13  were  primary
and  8  secondary  lesions.  The  authors  recommend  always
keeping  the  possibility  of  a  secondary  lesion  in  mind,  even
in  the  presence  of  a  unilateral  voluminous  lesion  [14].
In  case  of  multilocular  cystic  lesions  of  the  ovary,  with  no
solid  portion,  the  radiologist  should  look  for  lymph  node  or
peritoneal  involvement,  particularly  on  diffusion-weighted
MR  sequences,  which  would  indicate  secondary  locations.
The  potential  primary  sites  (the  appendix,  stomach,  and
colon)  should  also  be  carefully  examined.  CT  examination
may  also  help  the  radiologist  look  for  a primary  origin.
Fibroscopy  and  coloscopy  may  also  be  performed  before
treatment  depending  on  local  preferences.
Colorectal adenocarcinoma metastasesHistological appearance
Ovarian  metastasis  of  colorectal  carcinoma  mimics  the
mucinous  cystadenocarcinoma  type  of  epithelial  mucinous
H
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p
timage in the axial plane; d: T1-weighted fat-suppressed MR image
elate.
umor.  It  appears  as  a  tumoral  proliferation  consisting  of
ariably  sized  glandular  structures,  lined  with  a  multi-
tratiﬁed  epithelium  with  marked  cytonuclear  atypia.  There
re  often  large  areas  of  tumor  necrosis  known  as  ‘‘dirty
ecrosis’’,  a  good  indication  of  secondary  ovarian  lesions.
Even  histologically,  the  differential  diagnosis  between  a
rimary  malignant  mucinous  tumor  and  metastasis  of  a  colo-
ectal  adenocarcinoma  is  not  easy.  Immunohistochemistry
an  be  performed:  being  positive  for  CK20  and  negative  for
K7  antibodies  suggests  a  metastatic  origin  from  a  colorectal
ancer.
RI appearance
n  MRI,  the  stained  glass  appearance  of  a  multilocular  lesion
ith  loculi  on  T1-weighted  MR  images  of  variable  inten-
ity  is  typical.  The  quantity  of  solid  component  varies  [15]
nd  necrotic  components  which  are  hyperintense  with  T2-
eighted  MR  images  are  often  seen.  If  the  solid  part  is
bsent,  the  MRI  appearance  may  be  very  similar  to  that
f  a  benign  mucinous  cystadenoma.  Injection  of  gadolin-
um  shows  enhancement  of  the  septa  and  the  solid  part
hen  present  but  again,  the  appearance  may  be  similar  to
 mucinous  cystadenocarcinoma  (Fig.  4).  In  this  situation,
eidman’s  criteria  [3]  are  useful  for  guiding  the  diagnosis
etween  a primary  or  secondary  origin.
etastases of  gastric neoplasiaistological appearance
t  is  important  to  differentiate  between  gastric  linitis
lastica  (diffuse  adenocarcinoma)  and  the  intestinal
ype  where  the  secondary  ovarian  lesions  have  different
1130  P.-E.  Laurent  et  al.
Figure 5. Bilateral ovarian metastases from gastric adenocarcinoma; a: T2-weighted MR image in the axial plane; b: T1-weighted MR
image in the axial plane; c: diffusion-weighted MR image in the axial plane; d: T1-weighted fat-suppressed MR image in the axial plane
after intravenous administration of a gadolinium chelate. On the left, presence of a solid portion, which is hypointense on T2-weighting
image, hyperintense on diffusion-weighted image, and enhancing after gadolinium injection (arrows), corresponding to the area indicated
by the forceps on the macroscopic view on Fig. 4e; e: photograph shows gross appearance of the tumor which is a right ovarian mass with no
solid part. Forceps indicates solid portion on a, b, c and d; f: histologica
differentiated adenocarcinomatous proliferation composed of glands an
Table  1  Comparison  of  the  characteristics  of  ovarian
metastases  of  gastric  linitis  plastica,  and  intestinal  type
adenocarcinoma.
Gastric
primary
Gastric
linitis
plastica
Intestinal
type
Mean  age  40  50  and  over
Ovarian  metastases  Krukenberg  Intestinal  type
Solid  component  +++  +
Cystic  areas  +  +++
Microscopic  appearance
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Mucinous  glands  Rare  Numerous
haracteristics  [16].  The  anatomopathological  appearance
s  set  out  in  Table  1  [16].  Patients  with  gastric  linitis  plastica
re  signiﬁcantly  younger  (a  mean  of  40  years  old),  and  the
astric  neoplasia  is  generally  occult,  often  revealed  by
redominantly  solid,  Krukenberg  type,  secondary  pelvic
asses.  On  the  contrary,  patients  with  intestinal  type
esions  are  older  (generally  over  50),  and  the  primary  site  is
nown.  Generally,  the  intestinal  type  of  ovarian  metastases
re  predominantly  multilocular  cysts  with  a  mucoid  content
nd  a  solid  part  [17]  (Fig.  5).  Histological  examination
hows  carcinomatous  structures  surrounded  by  cells  with
arked  atypia  and  a  mucosecretion  vacuole.
a
b
t
tl appearance ×20 magniﬁcation. The tumor contains a moderately
d tumor trabeculae.
RI appearance
varian  metastases  of  an  intestinal  type  gastric  adeno-
arcinoma  closely  mimic  epithelial  mucinous  lesions,  are
redominantly  cystic,  and  contain  many  loculi  of  variable
ntensity  on  T1-weighted  MR  images.  An  enhanced  solid  com-
onent  may  be  seen,  but  is  not  systematically  present  [17]
Fig.  5).
ther primaries
here  are  few  descriptions  in  the  literature  of  the  radio-
ogical  appearance  of  other  secondary  lesions,  whether
ucinous  or  not.  Macroscopically,  their  appearance  varies
rom  predominantly  pure  cystic  lesions,  to  predominantly
olid  KT  lesions.  Histologically,  pancreatic  or  biliary  metas-
ases  are  very  often  mucinous  lesions  similar  to  colorectal
etastases  [15].
seudomyxoma peritonei
istological appearance
varian  involvement  is  common  in  cases  of  pseudomyxoma
eritonei.  The  origin  of  these  lesions  has  been  discussed  for
 long  time,  but  today  it  is  agreed  that  the  ovarian  lesions
re  secondary,  and  the  site  of  the  primary  lesion  is  the
ppendix.  This  appendicular  tumor  obstructs  the  appendix,
ecomes  complicated  by  a  mucocele,  then  by  spreading
o  the  peritoneum.  Secondary  ovarian  implantation  is
ypical,  and  for  a  long  time  was  wrongly  considered  to
MRI  of  ovarian  mucin-producing  tumors  1131
Figure 6. Benign serous cystadenoma. MR images show paucilocular formation with a narrow septum (arrows); a: T2-weighted MR image
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Cin the axial plane; b: T1-weighted MR image in the axial plane; c: T
fat-suppressed MR image in the sagittal plane after intravenous adm
be  the  primary  site.  Where  involvement  is  unilateral,  the
right  ovary  is  more  readily  affected,  probably  due  to  the
proximity  of  the  appendix  [18].
Macroscopically,  involvement  is  typically  bilateral,  with
voluminous  multilocular  lesions.  These  loculi  contain  mucin
bags  of  jelly  [2].  Microscopic  examination  shows  pools  of
mucus  that  may  include  strips  of  mucinous  epithelium  with
a  variable  degree  of  atypia  depending  on  the  grade  of  the
tumor  [19].
MRI appearance
There  are  several  MRI  features  indicating  pseudomyxoma.
These  include  ascites,  peritoneal  nodules  which  can  be  dis-
tinguished  from  the  adjacent  ascites  on  T2-weighted  MR
images  and  after  intravenous  administration  of  a  gadolinium
chelate  [20,21],  scalloping  of  peritoneal  organs,  particu-
larly  the  liver  [20—22],  and  common  ovarian  involvement  in
the  form  of  multilocular  cystic  lesions,  mimicking  a  primary
mucinous  lesion  [15]
Serous epithelial tumors
Histological appearance
The  typical  appearance  of  a  serous  tumor  is  a  unilocular  cyst
with  a  pure  liquid  content,  smaller  than  primary  mucinous
lesions  (Fig.  6).  In  some  cases,  it  may  be  paucilocular.  As
for  mucinous  lesions,  papillary  projections  are  possible
and  suggest  a  borderline  serous  lesion.  These  papillary
projections  are  generally  larger,  and  more  easily  seen  than
those  observed  in  mucinous  lesions.  The  presence  of  a
solid  portion  can  suggest  a  serous  cystadenocarcinoma  but
benign  solid  portions  have  also  been  described  in  cases  of
P
o
gighted fat-suppressed MR image in the axial plane; d: T1-weighted
ration of a gadolinium chelate.
varian  cystadenoﬁbroma.  Finally,  bilateral  involvement  is
ore  common  than  for  mucinous  lesions.
Microscopically,  these  tumors  are  covered  by  serous
pithelial  cells  (without  mucosecretory  activity)  with  a  cen-
ral  nucleus.  Benign  tumors  consist  of  cystic  or  papillary
tructures  covered  by  a  layer  with  no  atypia,  mitosis,  or
pithelial  budding.  Borderline  forms  have  at  least  two  of
he  four  signs  described  above  (papillary  projections,  atypia,
itosis  or  epithelial  budding),  without  stromal  invasion.
erous  adenocarcinomas  are  characterized  by  stromal  inva-
ion  and  many  atypia.
RI appearance
n  MRI,  benign  serous  cystadenoma  typically  presents  as
 uni-  or  pauci-locular  cyst,  with  a purely  liquid  content,
niformly  hyperintense  on  T2-weighted  MR  images  (Fig.  6).
he  presence  of  papillary  projections  suggests  a  borderline
ype.  A  solid  portion  may  be  seen  in  benign  cystadenoﬁ-
roma  lesions  or  in  malignant  serous  cystadenocarcinomas.
here  a solid  part  is  present,  indications  of  a  benign  cys-
adenoﬁbroma  are  hypointensity  of  the  solid  portion  on
2-weighted  MR  images,  the  absence  of  hyperintensity  on
iffusion-weighted  images,  and  a  type-1  enhancement  curve
n  perfusion  imaging  [1]. On  the  contrary,  a  tissue  portion
nhancing  with  a  type-3  curve  must  be  suspected  of  being  a
erous  cystadenocarcinoma  [11].
onclusionresence  of  a  multilocular  cystic  ovarian  lesion  with  loculi
f  varying  intensity  on  T1-weighted  MR  images  must  sug-
est  a  mucin-producing  ovarian  lesion.  MRI  can  provide
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dditional  useful  diagnostic  information  that  helps  dis-
riminate  between  the  different  entities.  The  differential
iagnosis  is  often  tricky  due  to  overlapping  in  radiolog-
cal  appearance  of  these  lesions.  The  radiologist  has  a
ivotal  role  as  he  should  distinguish  between  primary
nd  secondary  tumors,  integrating  the  clinical  context  to
eighten  diagnostic  capabilites.  The  size  of  the  lesions  and
heir  unilateral  or  bilateral  character  may  also  guide  the
adiologist  but  these  criteria  are  not  perfect.  Presence  of
 mucinous  lesion  must  systematically  lead  to  a  search  for
 primary  gastrointestinal  tract  lesion  (appendix,  colon,
tomach)  and  to  lymph  node  or  peritoneal  involvement.
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